Rout Namita, Kumar Sudhir, Jaganmohan Shanmugam, Murugan Vadivel
Centre for Biotechnology, Anna University, Chennai 600025, India.
Vaccine. 2007 Apr 12;25(15):2778-86. doi: 10.1016/j.vaccine.2006.12.056. Epub 2007 Jan 10.
White Spot Syndrome Virus (WSSV) is a major cause of mortality in shrimp and poses a huge threat to aquaculture industry. Till now no comprehensive or individual strategy has been established to combat white spot disease. Previous efforts by other investigators have given insight of protein vaccination and its efficacy to protect shrimp against WSSV infection. In this study, we have explored the protective efficacy of DNA vaccination and tissue distribution of the immunised recombinant plasmid in black tiger shrimp (Penaeus monodon). Four recombinant constructs were generated by inserting four genes encoding the WSSV structural proteins VP15, VP28, VP35 and VP281 individually into DNA vaccine vector pVAX1. Expression of these proteins from the recombinant plasmids was confirmed in vitro in CHO cell lines. For vaccination experiments, shrimp were immunised with these DNA constructs and later challenged with WSSV. A significant level of protection was offered by the plasmids encoding VP28 or VP281 till 7 weeks whereas protein vaccination failed to protect vaccinated shrimp after 3 weeks of first immunisation. In addition, our tissue distribution study revealed the persistence of immunised DNA at least upto 2 months in the injected shrimp muscle. Thus, our results suggest that DNA vaccination strategy will have potential utility against WSSV infection in shrimp cultivation.
白斑综合征病毒(WSSV)是导致对虾死亡的主要原因,对水产养殖业构成巨大威胁。到目前为止,尚未建立全面或单独的策略来对抗白斑病。其他研究人员之前的努力已经深入了解了蛋白质疫苗接种及其保护对虾免受WSSV感染的功效。在本研究中,我们探索了DNA疫苗接种的保护效果以及免疫重组质粒在黑虎虾(斑节对虾)中的组织分布。通过将四个编码WSSV结构蛋白VP15、VP28、VP35和VP281的基因分别插入DNA疫苗载体pVAX1中,构建了四种重组质粒。这些重组质粒所表达的蛋白质在体外CHO细胞系中得到了证实。在疫苗接种实验中,用这些DNA构建体对虾进行免疫,随后用WSSV进行攻毒。编码VP28或VP281的质粒在7周内提供了显著水平的保护,而蛋白质疫苗接种在首次免疫3周后未能保护接种疫苗的对虾。此外,我们的组织分布研究表明,免疫后的DNA在注射的对虾肌肉中至少持续存在2个月。因此,我们的结果表明,DNA疫苗接种策略在对虾养殖中对抗WSSV感染方面具有潜在的应用价值。